Description: Qrons Inc., a preclinical stage biotechnology company, engages in developing cell-based solutions to combat neuronal injuries, primarily focusing on traumatic brain injuries. Qrons Inc. has a license and research funding agreement with Ariel University R&D Co., Ltd. for the development and commercialization of products for neuronal tissue regeneration and repair. The company was formerly known as BioLabMart Inc. and changed its name to Qrons Inc. in August 2017. Qrons Inc. was founded in 2016 and is headquartered in Miami, Florida.
Home Page: qrons.com
28-10 Jackson Avenue
Long Island City,
NY
11101
United States
Phone:
212 945 2080
Officers
| Name | Title |
|---|---|
| Mr. Jonah Martin Meer | Co-Founder, CEO, CFO, Sec. & Director |
| Mr. Ido Merfeld Ph.D. | Co-Founder, Pres & Director |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 144.778 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |